| Ident. | Authors (with country if any) | Title |
|---|
| 000C13 |
Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database |
| 000F09 |
Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Shigeyuki Kojima [Japon] ; Satsuki Mitsuma [Japon] ; Yukari Sekiguchi [Japon] ; Toshihide Kanesaka [Japon] ; Satoshi Kuwabara [Japon] | Dopamine Agonist-induced Antecollis in Parkinson's Disease |
| 000F60 |
Louis C. S. Tan [Singapour, États-Unis] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour, États-Unis] ; Raymond K. K. Lee [Singapour] ; Yiong-Huak Chan [Singapour] ; Nigel C. K. Tan [Singapour] | Bromocriptine Use and the Risk of Valvular Heart Disease |
| 001041 |
Masaaki Hirayama [Japon] ; Tomohiko Nakamura [Japon] ; Norio Hori [Japon] ; Yasuo Koike [Japon] ; Gen Sobue [Japon] | The Video Images of Sleep Attacks in Parkinson's Disease |
| 001592 |
Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne] | Meta-analysis of heart valve abnormalities in parkinson's disease patients treated with dopamine agonists |
| 001847 |
Ji-Youn Kim [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; SEUNG WOO PARK [Corée du Sud] ; WON YONG LEE [Corée du Sud] | Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists |
| 001967 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study |
| 001F71 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Trial of subtherapeutic pergolide in de novo Parkinson's disease |
| 002181 |
Pinky Agarwal [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis] | Diagnosis and management of pergolide-induced fibrosis |
| 002343 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 002477 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease |
| 002813 |
| DA agonists: Ergot derivatives: Pergolide |
| 002919 |
William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie] | Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations |
| 002C37 |
J. Kulisevsky [Espagne] ; C. Garcia-Sanchez [Espagne] ; M. L. Berthier [Espagne] ; M. Barbanoj [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; A. Estevez-Gonzalez [Espagne] | Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease : A two-year follow-up study of previously untreated patients |
| 002D07 |
J. E. Ahlskog [États-Unis] ; R. J. Uitti [États-Unis] ; M. K. O'Connor [États-Unis] ; D. M. Maraganore [États-Unis] ; J. Y. Matsumoto [États-Unis] ; K. F. Stark [États-Unis] ; M. F. Turk [États-Unis] ; O. L. Burnett [États-Unis] | The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease |
| 002F03 |
J. Winkelmann [Allemagne] ; T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne] | Treatment of restless leg syndrome with pergolide : An open clinical trial |
| 003237 |
J. F. Lipinski [États-Unis] ; F. R. Sallee [États-Unis] ; C. Jackson [États-Unis] ; G. Sethuraman [États-Unis] | Dopamine agonist treatment of Tourette disorder in children : Results of an open-label trial of pergolide |
| 003540 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 003588 |
G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli | Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study |
| 003648 |
C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. Yahr | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease |
| 003A90 |
J. G. De Yebenes ; S. Fahn ; S. Lovelle ; V. Jackson-Lewis ; P. Jorge ; M. A. Mena ; J. Reiriz ; J. C. Bustos ; C. Magarinos ; A. Martinez | Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease |
